Short answer
Sionna Therapeutics, Inc. (SION) filed an 8-K current report with the SEC on June 18, 2026 reporting Item 5.07 (Submission of Matters to a Vote of Security Holders). All four Class II director nominees elected to terms ending at the 2029 annual meeting.
Sionna Therapeutics, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 5.07 · Submission of Matters to a Vote of Security Holders
- All four Class II director nominees elected to terms ending at the 2029 annual meeting
- Joanne Viney received 41,931,706 votes, while Peter Thompson had the highest withholdings at 2,346,405
- Deloitte & Touche LLP ratified as independent auditor for fiscal year 2026
- Auditor ratification received 43,291,215 votes for versus 1,198 against and 507 abstentions
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Sionna Therapeutics, Inc. 8-K filings
Get the next SION 8-K as it lands
Follow SION for push alerts, or ask the research agent what this filing means.